Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-cell Renal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02262455
What this trial is testing

Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

Who this might be right for
Ovarian CancerFallopian Tube CancerEndometrial Cancer+1 more
Santa Maria Biotherapeutics 32
Early research (Phase 1)Study completedNCT02390843
What this trial is testing

Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors

Who this might be right for
RetinoblastomaClear Cell SarcomaRenal Cell Carcinoma+9 more
Emory University 13
Not applicableNot Yet RecruitingNCT07833085
What this trial is testing

CAIX-targeted PET/CT in Solid Tumors

Who this might be right for
Malignant Solid TumorsClear Cell Renal Cell CarcinomaLung Cancer (NSCLC)+1 more
Zhongnan Hospital 100
Large-scale testing (Phase 3)Looking for participantsNCT06661720
What this trial is testing

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRenal Cell Carcinoma (RCC)Stage II Renal Pelvis Cancer AJCC v8+1 more
Alliance for Clinical Trials in Oncology 1,040
Testing effectiveness (Phase 2)Study completedNCT00726323
What this trial is testing

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 74
Testing effectiveness (Phase 2)Study completedNCT00401128
What this trial is testing

Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
The Cleveland Clinic 9
Testing effectiveness (Phase 2)UnknownNCT05879471
What this trial is testing

68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 39
Testing effectiveness (Phase 2)WithdrawnNCT06361810
What this trial is testing

PSMA Therapy and Immunotherapy in Kidney Cancer

Who this might be right for
Metastatic Renal Cell CarcinomaMetastatic Clear Cell Renal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Ended earlyNCT06191796
What this trial is testing

Study of Zanzalintinib (XL092) + AB521 and Zanzalintinib + AB521 + Nivolumab in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Other Advanced Solid Tumors (STELLAR-009)

Who this might be right for
Advanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid Tumors
Exelixis 25
Very early researchLooking for participantsNCT07645690
What this trial is testing

The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Unresectable or Metastatic Clear Cell Renal Cell Carcinoma
Chinese PLA General Hospital 30
Large-scale testing (Phase 3)Active Not RecruitingNCT04810078
What this trial is testing

Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread

Who this might be right for
Clear Cell Renal Cell Carcinoma
Bristol-Myers Squibb 681
Early research (Phase 1)Active Not RecruitingNCT06049576
What this trial is testing

Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
City of Hope Medical Center 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT05220267
What this trial is testing

Anlotinib Plus Sintilimab as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma

Who this might be right for
Non Clear Cell Renal Carcinoma
Sun Yat-sen University 44
Testing effectiveness (Phase 2)Ended earlyNCT03334409
What this trial is testing

Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+2 more
Academic and Community Cancer Research United 5
Large-scale testing (Phase 3)Active Not RecruitingNCT05239728
What this trial is testing

Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 1,800
Early research (Phase 1)Ended earlyNCT04272034
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more
Incyte Corporation 105
Testing effectiveness (Phase 2)Looking for participantsNCT06699602
What this trial is testing

Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT06389682
What this trial is testing

Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients

Who this might be right for
Clear Cell Renal Cell Carcinoma Metastatic
Norroy Bioscience Co., LTD 19
Testing effectiveness (Phase 2)Study completedNCT01164228
What this trial is testing

Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney Cancer
ECOG-ACRIN Cancer Research Group 87
Testing effectiveness (Phase 2)Study completedNCT03075423
What this trial is testing

Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC

Who this might be right for
Metastatic Renal Cell Carcinoma
Goethe University 316
Next Page